Autonomix Medical, Inc. Common Stock (AMIX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Autonomix Medical, Inc. Common Stock (AMIX) has a cash flow conversion efficiency ratio of -0.491x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.89 Million) by net assets ($5.89 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AMIX book value for net asset value and shareholders' equity analysis.
Autonomix Medical, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2022–2026)
This chart illustrates how Autonomix Medical, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Autonomix Medical, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Autonomix Medical, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rare Earth Magnesium Technology Group Holdings Limited
STU:GPS
|
0.016x |
|
Lion Energy Ltd
AU:LIO
|
-0.111x |
|
Wide Open Agriculture Ltd
AU:WOA
|
-0.429x |
|
HB Stockholdings Limited
NSE:HBSL
|
-0.126x |
|
Crown Confectionery Co Ltd Pref
KO:26490K
|
0.014x |
|
GGL Resources Corp
V:GGL
|
-0.023x |
|
Conico Ltd
AU:CNJ
|
-0.265x |
|
Juno Minerals Ltd
AU:JNO
|
-0.032x |
Annual Cash Flow Conversion Efficiency for Autonomix Medical, Inc. Common Stock (2022–2026)
The table below shows the annual cash flow conversion efficiency of Autonomix Medical, Inc. Common Stock from 2022 to 2026. For the full company profile with market capitalisation and key ratios, see Autonomix Medical, Inc. Common Stock market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | $5.89 Million | $-12.28 Million | -2.083x | -104.33% |
| 2025-03-31 | $8.10 Million | $-8.26 Million | -1.020x | -16.99% |
| 2024-03-31 | $7.63 Million | $-6.65 Million | -0.872x | +69.73% |
| 2023-03-31 | $644.00K | $-1.85 Million | -2.880x | -1356.83% |
| 2022-03-31 | $1.96 Million | $-387.31K | -0.198x | -- |
About Autonomix Medical, Inc. Common Stock
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresse… Read more